11 wyniki
This invention pertains to sesquiterpene lactones and sesquiterpene lactone-containing plant extracts and preparations for pharmaceutical uses, particularly the use of sesquiterpene lactones for the treatment of severe inflammatory disorders, for example, sepsis, septic shock, or septicemia.
A large
FIELD OF THE INVENTION
The present invention relates generally to sesquiterpene derivatives, and more specifically to deoxyelephantopin derivatives.
BACKGROUND OF THE INVENTION
The identification and validation of the potential benefits of phytocompounds with low toxicity, but effective for cancer
FIELD OF THE INVENTION
The present invention relates generally to a composition exhibiting synergistic inhibition of the expression and/or activity of inducible cyclooxygenase-2 (COX-2). More particularly, the composition comprises a combination of a diterpene triepoxide lactone species and a
The present application teaches the use of inhaled, inhibitory doses of trichothecenes to achieve localized protein synthesis downregulation to provide therapeutic benefit for conditions involving hyperactive production of proteins in the respiratory tract. These conditions include inflammatory
FIELD OF THE INVENTION
The present invention relates to inflammation, and novel combinations of active ingredients useful and synergistic for treating or preventing inflammation.
BACKGROUND OF THE INVENTION
Flavonoids are a diverse class of compounds found in a large variety of plants and herbs that
FIELD OF THE INVENTION
The present invention relates to inflammation, and novel combinations of active ingredients useful and synergistic for treating or preventing inflammation.
BACKGROUND OF THE INVENTION
Flavonoids are a diverse class of compounds found in a large variety of plants and herbs that
RELATED APPLICATION
This application is a national phase entry under 35 USC 371 of International Patent Application No. PCT/CN2015/076946 filed on 20 Apr. 2013, which claims priority from Chinese Application No. 2014102325900 filed on 28 May 2014, the disclosures of which are incorporated in their
INCORPORATION-BY-REFERENCE OF MATERIAL SUBMITTED ELECTRONICALLY
The instant application contains a Sequence Listing which has been submitted in ASCII format via EFS-Web and is hereby incorporated by reference in its entirety. Said ASCII copy, created on Mar. 3, 2017, is named P12589-05_ST25.txt and
BACKGROUND OF THE INVENTION
Development of safe and effective agents for reducing the risk of cancer and other chronic diseases is a high priority of contemporary medicine. Implementation of strategies for chemoprevention/chemoprotection is beset with many problems.
In the economically developed
The present invention refers to complexes between bilobalide, a sesquiterpene extracted from the leaves of Gingko biloba, and natural or synthetic phospholipids, to the preparation thereof and to the therapeutical use thereof. The complexes prepared according to the procedure described in the
The present invention relates to a process for obtaining (-)-guaiol from the oil of Callitris intratropica, to processes for encapsulation of the oil from Callitris intratropica, and to various uses of the oil or the encapsulated oil.
Recently there has been a noticeable trend towards the increasing